Sirish Kishore, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · Advanced Radiology and Interventional Associates Inc
Hospitals listed: Ahmc Seton Medical Center · Doctors Hospital of Manteca · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kishore’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133506 · Current
Licensed to practise in California · since 2014 · expires 2026-12-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Doctors Hospital of MantecaManteca, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 55% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Doctors Hospital of Manteca
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 230 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.49 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 700 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.1 to 0.56) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,462 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.24 to 6.39) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.57 to 4) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,152 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.3 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 60 · 183 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.4 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.8) · 379 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (339 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$5,695
Medicare paid this office $5,695 for 37 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasonic guidance for needle placement | 11 | $294 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $273 | $11 |
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 72 · Women 51% · Health risk score 2.69. Sicker patients than 9 in 10 peers; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 73% · Cancer 43% · Diabetes 38% · Chronic kidney disease 35% · Depression 30%.
The office billed $217,510, Medicare allowed $7,359 and paid $5,695; for 89 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 37 | 89 | 72 | 2.69 | $217,510 | $5,695 |
| 2023 | 23 | 62 | 73 | 3.02 | $112,987 | $3,127 |
| 2020 | 91 | 183 | 73 | 3.19 | $151,380 | $17,501 |
| 2019 | 317 | 790 | 73 | 2.84 | $683,305 | $78,495 |
| 2018 | 272 | 2,459 | 73 | 2.48 | $701,931 | $66,561 |
| 2017 | 263 | 6,247 | 74 | 2.61 | $1,415,613 | $136,312 |
| 2016 | 124 | 2,317 | 70 | 2.54 | $533,492 | $47,848 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $51 | $4 |
2020: 2 services
| Review by radiologist of ct guidance for needle placement | 14 | $950 | $68 |
| Ultrasonic guidance for blood vessel access | 11 | $148 | $13 |
2019: 14 services
| Insertion of central venous tube with port (5 years or older) | 30 | $9,558 | $319 |
| Review by radiologist of ct guidance for needle placement | 77 | $5,124 | $66 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 14 | $3,423 | $245 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 40 | $3,094 | $77 |
| Insertion of vena cava filter with review by radiologist | 12 | $2,371 | $182 |
| New patient visit (30+ min) | 35 | $2,332 | $67 |
| Needle biopsy of liver through skin | 17 | $1,407 | $74 |
| Needle biopsy of growth of abdominal cavity | 16 | $1,294 | $76 |
| Short return visit (20+ min) | 22 | $1,101 | $46 |
| Ultrasonic guidance for blood vessel access | 62 | $869 | $13 |
| Ultrasonic guidance for needle placement | 27 | $743 | $28 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 44 | $741 | $17 |
| Needle biopsy of muscle | 12 | $551 | $46 |
| Review by radiologist of additional artery image | 11 | $467 | $16 |
2018: 10 services
| Insertion of central venous tube with port (5 years or older) | 29 | $9,047 | $312 |
| Review by radiologist of ct guidance for needle placement | 58 | $3,006 | $50 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 31 | $2,561 | $80 |
| New patient visit (30+ min) | 37 | $2,552 | $69 |
| Drainage of fluid from abdominal cavity using imaging guidance | 13 | $1,141 | $82 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 44 | $732 | $17 |
| Needle biopsy of growth of abdominal cavity | 11 | $701 | $64 |
| Short return visit (20+ min) | 15 | $685 | $46 |
| Ultrasonic guidance for blood vessel access | 48 | $628 | $13 |
| Ultrasonic guidance for needle placement | 20 | $543 | $27 |
2017: 11 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 47 | $62,138 | $1,322 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $11,585 | $241 |
| Mri scan of abdomen before and after contrast | 18 | $7,753 | $431 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 15 | $5,255 | $350 |
| Review by radiologist of ct guidance for needle placement | 42 | $2,086 | $50 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 15 | $1,171 | $78 |
| Injection, gadobutrol, 0.1 ml | 19 | $481 | $0 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 31 | $390 | $0 |
| Ultrasonic guidance for needle placement | 11 | $314 | $29 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $278 | $16 |
| Ultrasonic guidance for blood vessel access | 14 | $171 | $12 |
2016: 5 services
| Mri scan of abdomen before and after contrast | 13 | $5,981 | $460 |
| Review by radiologist of ct guidance for needle placement | 28 | $1,395 | $50 |
| Injection, gadobutrol, 0.1 ml | 14 | $316 | $0 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $288 | $17 |
| Ultrasonic guidance for blood vessel access | 13 | $166 | $13 |
Money from drug and device companies
$10,290 in 2025
| 2025 | 7 | 10 | $9,500 | $10,290 |
| 2024 | 5 | 9 | $14,750 | $15,060 |
| 2023 | 10 | 19 | $7,250 | $11,062 |
| 2022 | 9 | 17 | $2,500 | $4,634 |
| 2021 | 6 | 10 | $5,500 | $6,955 |
| 2020 | 4 | 28 | $3,500 | $5,448 |
| 2019 | 7 | 45 | $5,000 | $8,501 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
InterVene, Inc.
$0
Held by this doctor · 2025 · Ownership Interest Represents Options Awarded on 9/25/24 To Purchase 50,000 Shares of Common Stock at A Exercise Price of $.04. As of December 31, 2025, 18,750 Options Were Vested and the Fmv Based on the Latest 409a Valuation Was $0.04/Share. Options Vest 25% Cliff Vesting on the One Year Anniversary of the Grant Date, Then 1/48 / Month Thereafter.
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Avantec Vascular | None | $6,000 | 1 payment
|
| Inquis Medical | Aventus | $3,500 | 2 payments
|
| Asahi Intecc Co. | None | $337 | 1 payment
|
| Boston Scientific | Obsidio | $277 | 3 payments
|
| Profound Medical | Tulsa-Pro | $107 | 1 payment
|
| Ge Healthcare | None | $46 | 1 payment
|
See all 10 published payments
| Asahi Intecc Co. | Meals · 2025-11-07 | None | $337 |
| Boston Scientific | Meals · 2025-10-18 | Obsidio | $58 |
| Boston Scientific | Travel · 2025-10-18 | Obsidio | $83 |
| Stryker | Meals · 2025-08-29 | Flowtriever | $24 |
| Inquis Medical | Consulting · 2025-08-08 | Aventus | $2,000 |
| Ge Healthcare | Meals · 2025-06-11 | None | $46 |
| Avantec Vascular | Consulting · 2025-05-27 | None | $6,000 |
| Profound Medical | Meals · 2025-04-14 | Tulsa-Pro | $107 |
| Inquis Medical | Consulting · 2025-03-31 | Aventus | $1,500 |
| Boston Scientific | Meals · 2025-01-08 | Therasphere Y90 Glass Microspheres 10 Gbq | $135 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $15,060
| Avantec Vascular | None | $13,000 | 1 payment
|
| Inquis Medical | Aventus | $1,750 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $104 | 1 payment
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $104 | 1 payment
|
| Histosonics | None | $102 | 1 payment
|
2023: $11,062
| Siemens Medical Solutions USA | None | $7,064 | 4 payments
|
| TriSalus Life Sciences | Trinav Infusion System | $1,449 | 3 payments
|
| Canon Medical Systems USA | Rotating Anode X-Ray Tube Assembly | $1,093 | 2 payments
|
| Bard Peripheral Vascular | None | $550 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $254 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $200 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $165 | 1 payment
|
| Galvanize Therapeutics | Aliya System | $130 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $91 | 1 payment
|
| Boston Scientific | Spyglass | $64 | 1 payment
|
2022: $4,634
| Canon Medical Systems USA | Rotating Anode X-Ray Tube Assembly | $3,276 | 2 payments
|
| TriSalus Life Sciences | Trinav Infusion System | $497 | 3 payments
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $312 | 2 payments
|
| Penumbra | Penumbra System | $125 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $124 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $122 | 5 payments
|
| Imactis | None | $88 | 1 payment
|
| Siemens Medical Solutions USA | None | $49 | 1 payment
|
| Bard Peripheral Vascular | None | $43 | 1 payment
|
2021: $6,955
| Inari Medical | Ct Thrombectomy System Kit | $5,861 | 4 payments
|
| TriSalus Life Sciences | Trinav Infusion System | $867 | 1 payment
|
| Walk Vascular | Jeti All in One Non-Sterile Kit | $85 | 1 payment
|
| Bard Peripheral Vascular | Venovo | $64 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $51 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $29 | 1 payment
|
2020: $5,448
| Inari Medical | Flowtriever | $4,339 | 7 payments
|
| Terumo Medical | Navicross | $881 | 12 payments
|
| Bard Peripheral Vascular | Venovo | $126 | 7 payments
|
| Surefire Medical | Precision Infusion System | $101 | 2 payments
|
2019: $8,501
| Surefire Medical | Precision Infusion System | $6,048 | 7 payments
|
| Boston Scientific | General Therapies | $1,565 | 24 payments
|
| Inari Medical | Flowtriever | $360 | 7 payments
|
| BTG International Canada | Therasphere-Bio | $154 | 1 payment
|
| Biocompatibles | Therasphere-Bio | $149 | 4 payments
|
| Medtronic USA | Embolization Spheres | $125 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $100 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Siemens Medical Solutions USA, Inc. · Perfusion Mri-Targeted Joint Emboliza??on To Diagnose and Treatneovascularity Associated With Chronic Musculoskeletal Pain of the Shoulder,Hip and K · 2025 | Their institution | $160,000 |
| Siemens Medical Solutions USA, Inc. · Perfusion Mri-Targeted Joint Embolization To Diagnose and Treat Neovascularity Associated With Chronic Musculoskeletal Pain of the Shoulder, Hip and K · 2023 | Their institution | $80,000 |
| Boston Scientific Corporation · Comparison of Early Venous Stenting Versus Physical Therapy in the Management of Lower Extremity Lymphedema Secondary To Non Thrombotic Malignant Venous Stenosis · 2021 | Their institution | $5,000 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1952613697
- Licence
- CA A133506, NY 2846971California A133506: Current · expires 2026-12-31
- Trained
- University of California, San Francisco School of Medicine, 2010
- Group
- Stanford Health Care · Advanced Radiology and Interventional Associates Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X); Federal specialty code 282N00000X (282N00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-07-10
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 525 E 68th St, New York, NY, 10065